Healthpeak Properties (HCP) (PEAK) Prices 15M Share Common Offering at $35/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
UPDATE: Healthpeak Properties Inc. (PEAK) Announces Sara Grootwassink Lewis to Board
November 5, 2019 5:20 PM EST(Updated - November 5, 2019 5:20 PM EST)
Healthpeak Properties, Inc. (NYSE: PEAK) today announced the appointment of Sara Grootwassink Lewis as an independent director to its Board of Directors, effective immediately. The appointment of Ms. Lewis expands the Board to eight directors, with an average director tenure of approximately five years.
Brian Cartwright, Healthpeak's Chairman of the Board, stated, "The addition of Sara... More
Healthpeak Properties (HCP) Announces Public Offering of Common Stock on Forward Basis
November 4, 2019 4:56 PM ESTHealthpeak Properties, Inc. (NYSE: HCP) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below. The underwriters are expected to be granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock.
BofA Securities and Morgan Stanley are acting as joint... More
HCP (HCP) PT Raised to $40 at RBC Capital
November 4, 2019 6:46 AM ESTRBC Capital analyst Michael Carroll raised the price target on HCP (NYSE: HCP) to $40.00 (from $36.00) while maintaining a Outperform rating.... More
